Literature DB >> 3463823

Direct examination of the clonality of carcinogen-induced colonic epithelial dysplasia in chimeric mice.

B A Ponder, M M Wilkinson.   

Abstract

The clonal composition of neoplastic foci was examined in histological sections of the colonic epithelium of azoxymethane (CAS: 25843-45-2)-treated CBA/Ca----C57BL/6J mouse aggregation chimeras, with the use of H-2 antigens as markers of cellular genotype. Each of 55 early neoplastic foci occurring at a mosaic patch boundary was composed of cells of a single genotype. Our results provide direct evidence that these foci arise from single crypts. In contrast, the epithelium of 5 of 17 larger adenomas was of mixed genotype: In 3, one genotype was represented only by a rim of cytologically normal epithelium derived from adjacent crypts, but in the other 2 the epithelium of both genotypes was dysplastic. One of these was probably a "collision" tumor arising from adjacent but independent foci; in the other, the minority component may have been derived from entrapped non-neoplastic crypts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463823

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer.

Authors:  N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

3.  Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Clonal structure of carcinogen-induced intestinal tumors in mice.

Authors:  Andrew T Thliveris; Linda Clipson; Alanna White; Jesse Waggoner; Lauren Plesh; Bridget L Skinner; Christopher D Zahm; Ruth Sullivan; William F Dove; Michael A Newton; Richard B Halberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

5.  Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission.

Authors:  W-M Wong; N Mandir; R A Goodlad; B C Y Wong; S B Garcia; S-K Lam; N A Wright
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

6.  Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages.

Authors:  A J Merritt; K A Gould; W F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Polyclonality of familial murine adenomas: analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions.

Authors:  Andrew T Thliveris; Richard B Halberg; Linda Clipson; William F Dove; Ruth Sullivan; Mary Kay Washington; Stephen Stanhope; Michael A Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

8.  Suppression of intestinal neoplasia by deletion of Dnmt3b.

Authors:  Haijiang Lin; Yasuhiro Yamada; Suzanne Nguyen; Heinz Linhart; Laurie Jackson-Grusby; Alexander Meissner; Konstantinos Meletis; Grace Lo; Rudolf Jaenisch
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 9.  The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.

Authors:  W F Dove; R T Cormier; K A Gould; R B Halberg; A J Merritt; M A Newton; A R Shoemaker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

10.  Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.

Authors:  Robert E Carroll; Robert A Goodlad; Aleksandra J Poole; Angela L Tyner; R Brooks Robey; Steven M Swanson; Terry G Unterman
Journal:  Growth Horm IGF Res       Date:  2009-04-29       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.